PeeVee.TV
   

  ログイン

ホーム 新規ユーザー登録

新着動画一覧

01

サムネイル

Threshold (THLD) Global Agreement with Merck KGaA

CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones. *********************** THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

投稿者:サイト名 karmastock
投稿日時:2012.2.5. 05:10
視聴回数:198回
お気に入り登録:0
カテゴリ: ビジネス全般  
タグ: merck   Nasdaq:THLD   THLD   threshold  

01

   
videovar
iPeeVee iPeeVee

会社概要 |  ソリューション |  お問い合わせ |  スタッフ募集 |  利用規約 |  プライバシーポリシー

Copyright (C) 2006-2020 PeeVee Corporation. All rights reserved.